Joseph Caprini to Thromboembolism
This is a "connection" page, showing publications Joseph Caprini has written about Thromboembolism.
Connection Strength
2.223
-
Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007 Jun; 131(6):872-84.
Score: 0.247
-
Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004 Mar 30; 109(12 Suppl 1):I4-8.
Score: 0.198
-
The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol. 2002 Mar; 21(1):78-85.
Score: 0.172
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
Score: 0.151
-
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019 11; 17(11):1966-1972.
Score: 0.144
-
Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis. Thromb Haemost. 2017 06 02; 117(6):1192-1198.
Score: 0.122
-
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27; 373(9):823-33.
Score: 0.108
-
Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost. 1995; 21 Suppl 4:59-62.
Score: 0.105
-
Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg. 1994 Nov; 20(5):751-8.
Score: 0.103
-
Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication. Foot Ankle Spec. 2014 Dec; 7(6):507-14.
Score: 0.101
-
Prevention of postoperative venous thromboembolism following laparoscopic cholecystectomy. Surg Endosc. 1994 Jul; 8(7):741-7.
Score: 0.101
-
Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective. Semin Thromb Hemost. 1991 Oct; 17(4):356-66.
Score: 0.083
-
Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991; 17 Suppl 3:304-12.
Score: 0.079
-
Thromboembolic diseases. Curr Probl Surg. 2008 Dec; 45(12):844-99.
Score: 0.069
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
Score: 0.063
-
Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005 Jul 11; 165(13):1458-64.
Score: 0.054
-
The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004 Nov; 2(11):1892-8.
Score: 0.052
-
Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001 Apr; 38(2 Suppl 5):12-9.
Score: 0.040
-
A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis. 2000 Apr; 9(3):253-62.
Score: 0.038
-
Matching risk with treatment strategies in deep vein thrombosis management. Blood Coagul Fibrinolysis. 1999 Aug; 10 Suppl 2:S37-43.
Score: 0.036
-
Heparin therapy-part I. Cardiovasc Nurs. 1977 May-Jun; 13(3):13-6.
Score: 0.031
-
Thromboelastography: measuring statistical probabilities. Semin Thromb Hemost. 1995; 21 Suppl 4:14-20.
Score: 0.026
-
Venous thromboembolism after hospital discharge. Semin Thromb Hemost. 1993; 19 Suppl 1:142-6.
Score: 0.023
-
International perspective on venous thromboembolism prophylaxis in surgery. Semin Thromb Hemost. 1991 Oct; 17(4):322-5.
Score: 0.021
-
Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost. 1991; 17 Suppl 3:313-8.
Score: 0.020
-
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol. 2008 Feb; 27(1):60-7.
Score: 0.016
-
Laboratory monitoring of continuous intravenous heparin therapy. Thromb Res. 1983 Jan 01; 29(1):91-4.
Score: 0.011
-
Altered coagulability in malignancy. IMJ Ill Med J. 1979 Nov; 156(5):384-90.
Score: 0.009